Literature DB >> 1100157

Studies on the hypotensive action of alpha-methyldopamine.

L Finch, A Hersom, P Hicks.   

Abstract

1. Intraventricular alpha-methyldopamine (50-200 mug) produced a dose-related fall in blood pressure in conscious spontaneously hypertensive rats. Pretreatment with intraventricular 6-hydroxydopamine prevented this hypotensive effect of alpha-methyldopamine. 2. The hypotensive effect of alpha-methyldopamine was prevented by intraventricular injection of phentolamine or desmethylimipramine, but not by intraperitoneal injection of haloperidol. 3. Pretreatment with U-14,624, a selective central dopamine-beta-hydroxylase inhibitor, prevented the hypotensive effect of alpha-methyldopamine. 4. Alpha-methyldopamine was considerably less potent than noradrenaline as a pressor agent in the pithed rat, but noradrenaline and alpha-methylnoradrenaline were found to be equipotent. 5. Alpha-methyldopamine (1-5 mg i.c.v.) reduced pressor responses elicited by electrical stimulation of the midbrain reticular formation in cats anaesthetized with chloralose. 6. It is concluded that the hypotensive action of alpha-methyldopamine in conscious animals involves intact central alpha-adrenergic neurones and a central adrenergic uptake mechanism for the formation of alpha-methylnoradrenaline.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1100157      PMCID: PMC1666681          DOI: 10.1111/j.1476-5381.1975.tb07590.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  31 in total

1.  In-vivo decarboxylation of alpha-methyl DOPA and alpha-methyl metatyrosine.

Authors:  A CARLSSON; M LINDQVIST
Journal:  Acta Physiol Scand       Date:  1962-01

2.  Central sympatho-inhibitory effects of intracisternal and intravenous administrations of noradrenaline in high doses.

Authors:  J N Sinha; H Schmitt
Journal:  Eur J Pharmacol       Date:  1974-09       Impact factor: 4.432

3.  The neurogenic component in the experimental hypertensive rat.

Authors:  L Finch
Journal:  Pharmacology       Date:  1971       Impact factor: 2.547

4.  Central adrenergic neurones and the initiation and development of experimental hypertension.

Authors:  G Haeusler; L Finch; H Thoenen
Journal:  Experientia       Date:  1972-10-15

5.  Central effects of sympathomimetic amines on the blood pressure.

Authors:  A Philippu; H Przuntek; G Heyd; A Burger
Journal:  Eur J Pharmacol       Date:  1971-07       Impact factor: 4.432

6.  In vivo inhibition of dopamine beta-hydroxylase by 1-phenyl-3-(2-thiazolyl)-2-thiourea (U-14,624).

Authors:  G A Johnson; S J Boukma; E G Kim
Journal:  J Pharmacol Exp Ther       Date:  1970-01       Impact factor: 4.030

7.  Modification of the central hypotensive effect of alpha-methyldopa by reserpine, imipramine and tranylcypromine.

Authors:  A K Kale; R S Satoskar
Journal:  Eur J Pharmacol       Date:  1970-01       Impact factor: 4.432

8.  A correlation between the hypotensive action of methyldopa and its depression of peripheral sympathetic function.

Authors:  G K Salmon; J D Ireson
Journal:  Arch Int Pharmacodyn Ther       Date:  1970-01

9.  A centrally mediated peripheral hypotensive effect of alpha-methyldopa.

Authors:  A J Ingenito; J P Barrett; L Procita
Journal:  J Pharmacol Exp Ther       Date:  1970-12       Impact factor: 4.030

10.  Effects of 6-hydroxydopamine on catecholamine containing neurones in the rat brain.

Authors:  N J Uretsky; L L Iversen
Journal:  J Neurochem       Date:  1970-02       Impact factor: 5.372

View more
  5 in total

1.  On the role of alpha-methyldopamine in the antihypertensive effect of alpha-methyldopa.

Authors:  P Waldmeier; P R Hedwal; L Maître
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1975       Impact factor: 3.000

2.  Studies on the marked antihypertensive properties of indapamide (SE 1520) in rats and cats [proceedings].

Authors:  L Finch; P E Hicks
Journal:  Br J Pharmacol       Date:  1976-10       Impact factor: 8.739

3.  The cardiovascular effects of intraventricularly administered histamine in the anaesthetised rat.

Authors:  L Finch; P E Hicks
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1976-05       Impact factor: 3.000

4.  Cardiovascular effects of dopamine after central administration into conscious cats.

Authors:  M D Day; A G Roach
Journal:  Br J Pharmacol       Date:  1976-12       Impact factor: 8.739

5.  Centrally induced hypotension and bradycardia after administration of alpha-methylnoradrenaline into the area of the nucleus tractus solitarii of the rat.

Authors:  W De Jong; F P Nijkamp
Journal:  Br J Pharmacol       Date:  1976-12       Impact factor: 8.739

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.